Page 3 - Y Mabs Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Y-mAbs Therapeutics, Inc (NASDAQ:YMAB) to Post Q2 2024 Earnings of ($0 14) Per Share, Wedbush Forecasts

Y-mAbs Therapeutics, Inc (NASDAQ:YMAB) to Post Q2 2024 Earnings of ($0 14) Per Share, Wedbush Forecasts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesY mabs therapeutics incSg americas securitiesTower research capitalBailard incAmeritas investment partners incCanaccord genuity groupSecurities exchange commissionChina universal asset management coY mabs therapeuticsFree reportY mabs therapeuticAbs therapeuticsGet free reportUniversal asset managementResearch capital

Analysts Offer Predictions for Y-mAbs Therapeutics, Inc s Q2 2024 Earnings (NASDAQ:YMAB)

Analysts Offer Predictions for Y-mAbs Therapeutics, Inc s Q2 2024 Earnings (NASDAQ:YMAB)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesBailard incSg americas securitiesY mabs therapeutics company profileTower research capitalChina universal asset management coCanaccord genuity groupAmeritas investment partners incY mabs therapeutics incY mabs therapeuticsFree reportY mabs therapeuticAbs therapeuticsGet free reportGenuity groupUniversal asset management

Y-mAbs Therapeutics (NASDAQ:YMAB) Trading 7 5% Higher

Y-mAbs Therapeutics (NASDAQ:YMAB) Trading 7 5% Higher
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Los angelesUnited statesVictory capital management incCapital partnersCanaccord genuity groupSecurities exchange commissionY mabs therapeutics company profileAcadian asset managementY mabs therapeutics incLos angeles capital managementY mabs therapeuticsGet free reportAbs therapeuticsExchange commissionAsset managementAngeles capital management

Y-mAbs Therapeutics, Inc (NASDAQ:YMAB) Q1 2024 Earnings Call Transcript

Y-mAbs Therapeutics, Inc (NASDAQ:YMAB) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Hong kongUnited statesCourtney duganSteen lisbyMike rossiAlec stranahanCanaccord genuityBo kruseMichael rossiSloan ketteringEtzer daroutSue smithInstitute of motherAssembly disassembly pretargeted radioimmunotherapyDrug market regulation chamberBeat childhood cancer research consortium

HBM Healthcare Investments achieves a balanced result in the 2023/2024 financial year - adhoc - Börsennachrichten

HBM Healthcare Investments achieves a balanced result in the 2023/2024 financial year - adhoc - Börsennachrichten
stock-world.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stock-world.de Daily Mail and Mail on Sunday newspapers.

United statesSwixx biopharmaSwiss national bankAmbrx pharmaceuticalsAdarx pharmaceuticalsLongboard pharmaceuticalsNational bankY mabs therapeuticsCathay biotechChinook therapeuticsPrometheus biosciencesAnnual general meeting